SynthesisFrontiers in oncology2025

A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer.

Jialin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.